REG - AdvancedAdvT Limited - Share Buyback Programme and Return of Capital

AdvancedAdvTAnnouncement

Today 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260304:nRSD2122Va&default-theme=true

RNS Number : 2122V  AdvancedAdvT Limited  04 March 2026

4 March 2026

AdvancedAdvT Limited

 

Share Buyback Programme and Potential Return of Capital

 

The Board of AdvancedAdvT Limited (AIM: ADVT) (the "Company") is pleased to
announce the launch of a share buyback programme (the "Buyback Programme") to
purchase up to £10 million ordinary shares of no par value of the Company
("Ordinary Shares"). The Board believes that the current market price of the
Ordinary Shares does not fully reflect the intrinsic value of the Group's
software operations and that the Buyback Programme represents an attractive
use of the Company's capital at current price levels.

 

Building a Resilient, Market‑Leading Platform

Since July 2023, the Group has completed nine acquisitions, deploying
approximately £45 million net of cash acquired to build a resilient,
market‑leading platform of mission‑critical software solutions generating
around £53 million of revenue, approximately 80 per cent. of which is
recurring and delivering adjusted EBITDA of not less than £14.4 million for
the 12 months ending 28 February 2026. This significant period of activity has
been matched by disciplined capital allocation, with the Group ending 28
February 2026 with a cash balance of approximately £96 million, demonstrating
both the quality of the businesses acquired and the platform's strong cash
generation.

 

Share Buyback Programme

The Company has appointed Singer Capital Markets Securities Limited to execute
and manage the Buyback Programme and has given an irrevocable instruction for
Singer Capital Markets to undertake market purchases on its behalf for a
period of 12 months. All trading decisions will be taken independently of the
Company.

 

The Buyback Programme permits the purchase of up to £10 million of Ordinary
Shares, with the maximum price payable being no more than 5 per cent. above
the average middle market quotation for the five business days immediately
preceding the date of any repurchase. The Directors have confirmed that
neither they nor persons connected with them intend to sell Ordinary Shares to
the Company during the programme. There is no guarantee that the Buyback
Programme will be implemented in full or that any purchases will be made.

 

Any Ordinary Shares acquired may be held in treasury and used to satisfy
future obligations under the Group's employee share schemes or as
consideration for future acquisitions, providing the Group with additional
flexibility in the execution of its strategy.  Alternatively, they may be
cancelled.

 

Potential Further Return of Capital

In addition to the Buyback Programme, the Board is also considering a further
substantial return of capital to Shareholders, potentially by way of a tender
offer, but will continue to assess all available capital allocation options,
including a tender offer, alongside, or as an alternative to, on‑market
buybacks.

 

Any decision on a further return of capital will take into account prevailing
market conditions, the Group's acquisition pipeline, and the Board's
assessment of the optimal capital structure for the Group at that time. There
can be no certainty that a tender offer will proceed or as to its terms. The
Board will update Shareholders as and when appropriate.

 

Strategy Unchanged

The Board remains focused on disciplined capital allocation, ensuring that all
decisions are aligned with the Group's long‑term strategy. The approval of
the Buyback Programme does not represent a change in that strategy. The Group
continues to see an attractive and active pipeline of bolt‑on acquisition
opportunities at valuations aligned with its sought characteristics and
expects to continue deploying capital into value‑accretive transactions
while retaining the flexibility to assess all options, including further
buyback mechanisms where appropriate. As an AIM‑quoted company, the Group
also retains the ability to access the equity capital markets should a larger
opportunity arise, which the Board views as an important strategic advantage.

 

Total Voting Rights

As at the date of this announcement, the Company's total issued share capital
consists of 137,125,806 Ordinary Shares, each carrying one voting right. The
Company does not hold any Ordinary Shares in treasury. The total number of
voting rights in the Company is 137,125,806.

 

The above figure may be used by Shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

This announcement contains inside information for the purposes of Article 7 of
EU Regulation 596/2014 as it forms part of domestic law in the United Kingdom
by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 AdvancedAdvT Limited
 Vin Murria, Chairperson

 Gavin Hugill, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)  Tel: 020 7496 3000
 Philip Davies / James Fischer

 KK Advisory (Investor Relations)                       Tel: 020 7039 1901
 Kam Bansil

 

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across
two business transformational areas: business solutions & healthcare
compliance, and human capital management.

 

AdvT is an agent for change. The Group enables the delivery of Artificial
Intelligence ("AI"), data analytics and business intelligence, all of which
are key future drivers for growth in these sectors where long term
digitisation trends are set to transform the workplace for professionals.

 

AdvT is developing both organically and through acquisitions, by expanding its
presence across adjacent markets, geographical boundaries and digital sectors.

 

Notes

 

It is anticipated that the maximum daily volume of any purchases of Ordinary
Shares under the Buyback Programme will not exceed 25% of the average daily
volume of the Ordinary Shares traded on the London Stock Exchange during the
20 trading days prior to the relevant purchase, in line with Article 3(3) of
Retained Regulation (EU) 2016/1052 setting out regulatory technical standards
for the conditions applicable to buy-back programmes
and stabilisation measures, as it forms part of retained EU law as defined
in the EU (Withdrawal) Act 2018 (the "MAR Buy-Back Regulation"). However, in
periods of general illiquidity in the Company's Ordinary Shares, purchases may
be made in excess of these volume limits. In such circumstances, the Company
will not be able to rely on the safe harbour provisions of the MAR Buy-Back
Regulation.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFXLLBQXLZBBL



            Copyright 2019 Regulatory News Service, all rights reserved